Skip to Content

Evonik Earnings: EBITDA Above Consensus but Significantly Below Prior Year on Weak Demand

Basic Materials Sector artwork

No-moat Evonik EVK reported third-quarter EBITDA of EUR 485 million, down 21% versus 2022 but 8% higher than the second quarter and 6% above Vara consensus. The year-on-year decline was mainly driven by continued weak demand for its specialty additives and smart materials segments. However, Evonik made progress toward achieving its cost-saving target of EUR 250 million for the year, currently reaching the 70% mark. Guidance for 2023 EBITDA of EUR 1.6 billion-EUR 1.8 billion was confirmed. We don’t expect to make a material change to our forecast of EUR 25 fair value estimate. At current levels, the shares look undervalued.

The volume development improved sequentially to negative 5% in the third quarter compared with negative 11% in the first half. Still, the price contribution to growth deteriorated to negative 6% in the third quarter compared with negative 1% in the first half due to a decline in selling prices as lower raw material costs were passed on to consumers.

Volumes declined across most segments, except for the nutrition and care segment, which managed to achieve a 5% increase in volumes. However, this growth was offset by a notable 10% price decline. The smart materials segment experienced the most significant downturn, with a substantial 12% decrease in volumes, driven by weakened demand across all market segments. Performance materials also faced challenges, with a 4% reduction in volumes and a 9% price deterioration, primarily due to sluggish downstream demand for its C4 products. Meanwhile, Specialty Additives grappled with an 11% volume decline, resulting from a combination of factors including weak end-customer demand, ongoing destocking in some regions, and increased exports from Asia into Europe and the United States. As a consequence of these developments, the 2023 EBITDA guidance for the specialty additives segment has been revised to indicate a performance “significantly lower than the previous year,” as opposed to “considerably lower.”

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Diana Radu

Equity Analyst
More from Author

Diana Radu, CFA, is an equity analyst for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. Based in Amsterdam, she covers European consumer packaged-goods and specialty chemicals companies.

Before joining Morningstar in 2022, Radu spent several years at Unilever, working in various corporate and commercial finance roles across Europe. Before that, she worked for two years as an equity analyst for BT Capital Partners in Romania.

Radu holds a bachelor's degree in finance and a master's degree in statistics and econometrics from Babes-Bolyai University in Romania. She also holds the Chartered Financial Analyst® designation.

Sponsor Center